Here are three things to know.
1. The single dose antibiotic is intended to treat bacterial vaginosis, the most common gynecologic infection in the country.
2. Solosec is the first oral antibiotic approved for the infection in more than a decade.
3. Symbiomix expects the drug to hit the market in the first quarter of 2018.
More articles on supply chain:
NIH issues $15M in grants for development of 3-D human tissue models
Biosimilars are getting approved, but few have hit the market — here’s why
6 drugmakers in the headlines
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
